Rat TNF-alpha Platinum ELISA

Also known as: Cachectin, Tumor necrosis factor alpha, DIF

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS622*

Cat. No. Size
BMS622 96 tests
BMS622TEN 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Rat TNF-alpha Platinum ELISA.

Click on image to view more information.

  • Data for Rat TNF-alpha Platinum ELISA.
Description

Description: The rat TNF-alpha ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of rat TNF-alpha.Platinum Kits undergo stringent in-house development, manufacture and quality-validation processes ensuring highest possible product performance and optimal lot-to-lot consistency.

TNF-alpha release is mainly triggered by viral infections, endotoxins, lipopolysaccharides or other bacterial components, by tissue injury, DNA-damage and by IL-1, PDFG and TNF-alpha itself. It is primarily expressed in macrophages, but also in monocytes, neutrophils, NK-cells, mast-cells, endothelial cells and activated lymphocytes. TNF-alpha expression in endothelial cells and fibroblasts can be induced by IL-17. The expression of other cytokines, chemokines, reactive oxygen intermediates, nitric oxide and prostaglandins is stimulated by TNF-alpha.

Multiple biological functions of TNF-alpha comprise cellular proliferation and differentiation, tumorigenesis, apoptotic or necrotic cell death (including certain tumor cell lines), immunoregulatory activities, lipid metabolism, coagulation and endothelial function. It promotes local or systemic inflammation (TNF-alpha is a potent pyrogen) and stimulates the acute phase response. Very high expressions of TNF-alpha after infection can lead to septic shock (TNF-alpha is highly cytotoxic.), whereas sustained low levels induce cachexia and inflammation. Dysregulation of TNF-alpha is involved in many diseases.

Details
Reactivity Rat
Sample Volume 50 uL
Suitable Sample Types cell culture supernatant, serum
Sensitivity 11.0 pg/mL
Standard Curve Range 39.1 - 2,500 pg/mL
Components Aluminium pouch(es) with a Microwell Plate coated with polyclonal antibody to rat TNF-alpha
Biotin-Conjugate anti-rat TNF-alpha polyclonal antibody
Streptavidin-HRP
Rat TNF-alpha Standard lyophilized, 5 ng/mL upon reconstitution
Sample Diluent
Assay Buffer Concentrate 20x (PBS with 1% Tween 20 and 10% BSA)
Wash Buffer Concentrate 20x (PBS with 1% Tween 20)
Substrate Solution (tetramethyl-benzidine)
Stop Solution (1M Phosphoric acid)
Blue-Dye
Green-Dye
Red-Dye
Adhesive Films
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
88-7501 Rat C-Reactive Protein (CRP) ELISA Kit ELISA RUO
85-86081 NFkB p65 (Total) InstantOne™ ELISA ELISA RUO
BMS625* Rat IL-6 Platinum ELISA ELISA RUO
BMS630* Rat IL-1 beta Platinum ELISA ELISA RUO
References

Citations: Szuster-Ciesielska,Agnieszka; Slotwinska,Maria; Stachura,Anna; Marmurowska-Michalowska,Halina; Dubas-Slemp,Halina; Bojarska-Junak,Agnieszka; Kandefer-Szerszen,Martyna. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008;32:(Link)

Szabolcs A,Varga IS,Varga C,Berk¢ A,Kaszaki J,Letoha T,Tiszlavicz L,S ri R,Lonovics J,Tak cs T.. Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitis. Eur J Pharmacol. 2006;532:187-193. (Link)

Wilms,Henrik; Rosenstiel,Philip; Sievers,Jobst; Deuschl,Gunther; Zecca,Luigi; Lucius,Ralph. Activation of microglia by human neuromelanin is NF-κB-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB Journal 2003;02-0314fje. (Link)

Ling,Y.L.; Meng,A.H.; Zhao,X.Y.; Shan,B.E.; Zhang,J.L.; Zhang,X.P.. Effect of cholecystokinin on cytokines during endotoxic shock in rats. World J Gastroenterol. 2001;7:667-671. (Link)

Rakonczay,Z.; Duda,E.; Kaszaki,J.; Ivanyi,B.; Boros,I.; Lonovics,J.; Takacs,T.. The anti-inflammatory effect of methylprednisolone occurs down-stream of nuclear factor-@kB DNA binding in acute... European Journal of Pharmacology 2003;464:217-227. (Link)

Letoha T,Somlai C,Takacs T,Szabolcs A,Jarmay K,Rakonczay Z Jr,Hegyi P,Varga I,Kaszaki J,Krizbai I,Boros I,Duda E,Kusz E,Penke B.. A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. World J Gastroenterol. 2005;11:990-999. (Link)

Letoha T,Somlai C,Tak cs T,Szabolcs A,Rakonczay Z Jr,J rmay K,Szalontai T,Varga I,Kaszaki J,Boros I,Duda E,Hackler L,Kurucz I,Penke B.. The proteasome inhibitor MG132 protects against acute pancreatitis. Free Radic Biol Med. 2005;39:1145-1151. (Link)

References: Kawane,K.; Ohtani,M.; Miwa,K.; Kizawa,T.; Kanbara,Y.; Yoshioka,Y.; Yoshikawa,H.; Nagata,S.. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 2006;443:998-1002. (Link)

Aggarwal,B.B.; Shishodia,S.; Takada,Y.; Jackson-Bernitsas,D.; Ahn,K.S.; Sethi,G.; Ichikawa,H.. TNF blockade: an inflammatory issue. Ernst.Schering.Res Found.Workshop 2006;161-186. (Link)

Pfeffer,K.. Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev. 2003;14:185-191. (Link)

McGuire,W.; Hill,A.V.; Allsopp,C.E.; Greenwood,B.M.; Kwiatkowski,D.. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-510. (Link)

Moehle,C.; Ackermann,N.; Langmann,T.; Aslanidis,C.; Kel,A.; Kel-Margoulis,O.; Schmitz-Madry,A.; Zahn,A.; Stremmel,W.; Schmitz,G.. Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 2006;84:1055-1066. (Link)

McLaughlin,P.J.; Aikawa,A.; Davies,H.M.; Ward,R.G.; Bakran,A.; Sells,R.A.; Johnson,P.M.. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 1991;51:1225-1229. (Link)

Aringer,M.; Smolen,J.S.. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther 2008;10:202(Link)

Aggarwal,B.B.. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann Rheum Dis 2000;59 Suppl 1:i6-16. (Link)

Davis,J.C.,Jr.; Mease,P.J.. Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic. Semin.Arthritis Rheum 2008;38:83-100. (Link)

Al-Aly,Z.. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl.Res 2008;151:233-239. (Link)

Holler,E.; Kolb,H.J.; Moller,A.; Kempeni,J.; Liesenfeld,S.; Pechumer,H.; Lehmacher,W.; Ruckdeschel,G.; Gleixner,B.; Riedner,C.; .. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011-1016. (Link)

Mukhopadhyay,S.; Hoidal,J.R.; Mukherjee,T.K.. Role of TNFalpha in pulmonary pathophysiology. Respir.Res 2006;7:125(Link)

Lorenzo,M.; Fernandez-Veledo,S.; Vila-Bedmar,R.; Garcia-Guerra,L.; De,Alvaro C.; Nieto-Vazquez,I.. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci. 2008;86:E94-104. (Link)

Aggarwal,B.B.. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev.Immunol 2003;3:745-756. (Link)

Beutler,B.; Bazzoni,F.. TNF, apoptosis and autoimmunity: a common thread?. Blood Cells Mol Dis 1998;24:216-230. (Link)

Pietrzak,A.T.; Zalewska,A.; Chodorowska,G.; Krasowska,D.; Michalak-Stoma,A.; Nockowski,P.; Osemlak,P.; Paszkowski,T.; Rolinski,J.M.. Cytokines and anticytokines in psoriasis. Clin Chim.Acta 2008;394:7-21. (Link)

Wong,M.; Ziring,D.; Korin,Y.; Desai,S.; Kim,S.; Lin,J.; Gjertson,D.; Braun,J.; Reed,E.; Singh,R.R.. TNFalpha blockade in human diseases: mechanisms and future directions. Clin Immunol 2008;126:121-136. (Link)

Mocellin,S.; Rossi,C.R.; Pilati,P.; Nitti,D.. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev. 2005;16:35-53. (Link)

Lin,J.; Ziring,D.; Desai,S.; Kim,S.; Wong,M.; Korin,Y.; Braun,J.; Reed,E.; Gjertson,D.; Singh,R.R.. TNFalpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 2008;126:13-30. (Link)

Tilg,H.; Moschen,A.R.. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 2008;14:222-231. (Link)

Gaur,U.; Aggarwal,B.B.. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem.Pharmacol 2003;66:1403-1408. (Link)

Nichols,D.; Chmiel,J.; Berger,M.. Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling. Clin Rev.Allergy Immunol 2008;34:146-162. (Link)

Varfolomeev,E.E.; Ashkenazi,A.. Tumor necrosis factor: an apoptosis JuNKie?. Cell 2004;116:491-497. (Link)

Norman,R.A.; Bogardus,C.; Ravussin,E.. Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. J Clin Invest 1995;96:158-162. (Link)

Morgan,M.J.; Kim,Y.S.; Liu,Z.G.. TNFalpha and reactive oxygen species in necrotic cell death. Cell Res 2008;18:343-349. (Link)